SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 223 | -98.7% | 0.00% | – |
Q1 2022 | $149,000 | -82.7% | 17,123 | -68.1% | 0.00% | -100.0% |
Q4 2021 | $860,000 | -34.4% | 53,728 | -24.6% | 0.00% | 0.0% |
Q3 2021 | $1,311,000 | +88.4% | 71,220 | +42.8% | 0.00% | 0.0% |
Q2 2021 | $696,000 | -19.3% | 49,891 | -14.8% | 0.00% | 0.0% |
Q1 2021 | $862,000 | -24.1% | 58,529 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,135,000 | +124.3% | 58,529 | +29.1% | 0.00% | 0.0% |
Q3 2020 | $506,000 | +39.8% | 45,329 | +69.6% | 0.00% | – |
Q2 2020 | $362,000 | +143.0% | 26,729 | +45.0% | 0.00% | – |
Q1 2020 | $149,000 | -6.3% | 18,429 | +11.4% | 0.00% | – |
Q4 2019 | $159,000 | -9.1% | 16,550 | 0.0% | 0.00% | – |
Q3 2019 | $175,000 | +8.7% | 16,550 | +18.0% | 0.00% | – |
Q2 2019 | $161,000 | -14.4% | 14,028 | -4.2% | 0.00% | – |
Q1 2019 | $188,000 | +93.8% | 14,650 | -6.7% | 0.00% | – |
Q4 2018 | $97,000 | -42.9% | 15,700 | -2.8% | 0.00% | – |
Q3 2018 | $170,000 | -28.3% | 16,150 | 0.0% | 0.00% | – |
Q2 2018 | $237,000 | – | 16,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,376,968 | $13,247,000 | 23.08% |
Aquilo Capital Management, LLC | 1,154,356 | $11,099,000 | 4.17% |
VHCP Management II, LLC | 474,015 | $4,558,000 | 1.20% |
AWM Investment Company, Inc. | 474,344 | $4,561,000 | 0.89% |
Alphabet Inc. | 1,112,473 | $10,696,000 | 0.65% |
BVF INC/IL | 845,405 | $8,129,000 | 0.62% |
Novo Holdings A/S | 931,099 | $8,948,000 | 0.58% |
Artal Group S.A. | 500,000 | $4,808,000 | 0.19% |
Rock Springs Capital Management LP | 525,000 | $5,048,000 | 0.16% |
Granahan Investment Management | 148,867 | $1,431,000 | 0.07% |